Search: onr:"swepub:oai:gup.ub.gu.se/319586" >
Bilirubin levels an...
Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data
-
Aoki, Y. (author)
-
Cabrera, C. S. (author)
-
Ouwens, M. (author)
-
show more...
-
Bamberg, K. (author)
-
- Nyström, Jenny, 1972 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi,Institute of Neuroscience and Physiology
-
Raz, I. (author)
-
Scirica, B. M. (author)
-
Hamren, B. (author)
-
Greasley, P. J. (author)
-
Rekic, D. (author)
-
show less...
-
(creator_code:org_t)
- 2022-06-21
- 2022
- English.
-
In: Plos One. - : Public Library of Science (PLoS). - 1932-6203. ; 17:6
- Related links:
-
https://gup.ub.gu.se...
-
show more...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- ObjectiveTo evaluate if previously found associations between low serum bilirubin concentration and kidney function decline is independent of hemoglobin and other key confounders. Research design and methodsClinical trial data from the SAVOR-TIMI 53 trial as well as the UK primary care electronic healthcare records, Clinical Practice Research Datalink (CPRD), were used to construct three cohorts of patients at risk of chronic kidney disease (CKD). The randomized clinical trial (RCT) cohort from the subset of SAVOR-TIMI 53 trial consisted of 10,555 type-2 diabetic patients with increased risk of cardiovascular disease. The two observational data cohorts from CPRD consisted of 71,104 newly diagnosed type-2 diabetes (CPRD-DM2) and 82,065 newly diagnosed hypertensive (CPRD-HT) patients without diabetes. Cohorts were stratified according to baseline circulating total bilirubin levels to determine association on the primary end point of a 30% reduction from baseline in estimated glomerular filtration rate (eGFR) and the secondary end point of albuminuria. ResultsThe confounder adjusted hazard ratios of the subpopulation with lower than median bilirubin levels compared to above median bilirubin levels for the primary end point were 1.18 (1.02-1.37), 1.12 (1.05-1.19) and 1.09 (1.01-1.17), for the secondary end point were 1.26 (1.06-1.52), 1.11 (1.01-1.21) and 1.18 (1.01-1.39) for SAVOR-TIMI 53, CPRD-DM2, CPRD-HT, respectively. ConclusionOur findings are consistent across all cohorts and endpoints: lower serum bilirubin levels are associated with a greater kidney function decline independent of hemoglobin and other key confounders. This suggests that increased monitoring of kidney health in patients with lower bilirubin levels may be considered, especially for diabetic patients.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Keyword
- urinary albumin excretion
- serum bilirubin
- japanese patients
- disease
- association
- risk
- nephropathy
- progression
- Science & Technology - Other Topics
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
-
Plos One
(Search for host publication in LIBRIS)
To the university's database
- By the author/editor
-
Aoki, Y.
-
Cabrera, C. S.
-
Ouwens, M.
-
Bamberg, K.
-
Nyström, Jenny, ...
-
Raz, I.
-
show more...
-
Scirica, B. M.
-
Hamren, B.
-
Greasley, P. J.
-
Rekic, D.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
- Articles in the publication
-
Plos One
- By the university
-
University of Gothenburg